Back to
HighTower Advisors, LLC
TGTX
Showing 8 of 31 quarters
Position history for
HighTower Advisors, LLC's holdings in TG Therapeutics, Inc.
Yes. HighTower Advisors holds 20,250 shares of TGTX (TG Therapeutics), worth $1.1M, as of its Q2 2026 13F filing. It reduced the position by 5,023 shares (-19.9%) from Q1 2026. HighTower Advisors has held TGTX in every 13F on record since Q4 2018, 31 quarterly filings.
Current Value
$1.1M
Current Shares
20,250
Total Value Change
+$818,535
Total Shares Change
+7,724
Quarter-by-Quarter History